Literature DB >> 19049252

Validation of the use of nonnaive surgically catheterized rats for pharmacokinetics studies.

Sujal V Deshmukh1, Jessica Durston, Nirah H Shomer.   

Abstract

Although large animals, such as dogs and nonhuman primates, often are used for more than 1 pharmacokinetics study, common practice is to use only naive rodents for pharmacokinetics studies. We undertook a series of studies to validate whether surgically cannulated nonnaive rats could be used again after a 7-d washout. When vascular catheters are cared for appropriately, we find that they remain patent for more than 2 wk, with negligible drug carryover. Hematocrit decreased approximately 11% after pharmacokinetics studies but rebounded to prestudy levels after a 7-d washout. We empirically tested whether drugs known to alter drug disposition (1-aminobenzotriazole and quinidine) had residual effects on drug disposition after a 7-d washout and found that they did not. This finding suggests that after a 7-d washout, nonnaive rats likely would produce pharmacokinetics data similar to those of naive rats. We also tested reference compounds in naive and nonnaive rats and found no difference in pharmacokinetics parameters. Using surgically cannulated rats for a second study was feasible because of the relatively noninvasive nature of pharmacokinetics sampling (unrestrained rats attached to automated blood samplers). In addition, reusing surgically altered animals yields considerable cost savings. Our studies indicate that pharmacokinetics parameters did not differ significantly between naive and nonnaive rats. Cost-benefit analysis, monetary considerations, and validation studies support using rats for a second study after a 7-d washout period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049252      PMCID: PMC2687136     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  17 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Pharmacology of drugs that alter multidrug resistance in cancer.

Authors:  J M Ford; W N Hait
Journal:  Pharmacol Rev       Date:  1990-09       Impact factor: 25.468

3.  Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity.

Authors:  G R Matzke; R F Frye; J J Early; R J Straka; S W Carson
Journal:  Pharmacotherapy       Date:  2000-02       Impact factor: 4.705

4.  The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.

Authors:  Marta Robert; Miquel Salvà; Rosa Segarra; Marco Pavesi; Ramón Esbri; David Roberts; Georg Golor
Journal:  Drug Metab Dispos       Date:  2007-04-16       Impact factor: 3.922

5.  Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys.

Authors:  Suresh K Balani; Tong Zhu; Tian J Yang; Zhi Liu; Bing He; Frank W Lee
Journal:  Drug Metab Dispos       Date:  2002-10       Impact factor: 3.922

6.  An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies.

Authors:  P Chandrani Gunaratna; Peter T Kissinger; Candice B Kissinger; James F Gitzen
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Jan-Feb       Impact factor: 1.950

7.  The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.

Authors:  Marika Pasternyk Di Marco; David J Edwards; Irving W Wainer; Murray P Ducharme
Journal:  Life Sci       Date:  2002-07-26       Impact factor: 5.037

8.  Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.

Authors:  G Engel; U Hofmann; H Heidemann; J Cosme; M Eichelbaum
Journal:  Clin Pharmacol Ther       Date:  1996-06       Impact factor: 6.875

9.  Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.

Authors:  Maria L Veronese; Lisa P Gillen; Joanne P Burke; Ellen P Dorval; Walter W Hauck; Ed Pequignot; Scott A Waldman; Howard E Greenberg
Journal:  J Clin Pharmacol       Date:  2003-08       Impact factor: 3.126

10.  In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology.

Authors:  B A Mico; D A Federowicz; M G Ripple; W Kerns
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

View more
  1 in total

1.  1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology.

Authors:  Paul R Ortiz de Montellano
Journal:  Med Chem (Los Angeles)       Date:  2018-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.